Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1960 participants.

Also called NCT05454150

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,960 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05454150
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05454150. Randomized; no masking; primary purpose treatment. Start 2023-04-19 (actual); primary completion 2025-10-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)
Acronym
BEST
Condition
Aortic Valve Stenosis
Intervention (Device)
balloon-expandable valve
Intervention (Device)
self-expanding valve
Lead sponsor
University Hospital, Lille (class: other)
Collaborator
Ministry of Health, France (class: other government)
Collaborator
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (class: other)

Record details

Record id
cardio:ct-nct05454150
Content hash
19cd736a8bb4f3bfec224090c4e2ae44084944202c5e5652e8ac857d1e9c57e4